Latest Period
Q1 2026
Security Snapshot
SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) Institutional Ownership
CUSIP: 868459108
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
326
Shares (Excl. Options)
58,220,522
Price
$51.69
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- SUPN on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 58,220,522
- Total 13F value
- $3,007,204,873
- Portfolio coverage rank
- 0%
- Share change
- +1,099,426
- Value change
- +$59,274,476
- Number of holders
- 326
- Shares outstanding
- 57,671,650
- SEC-reported price per share
- $48.21
- Insider filing price
- $48.21
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock is tracked under CUSIP 868459108.
- 326 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 332 to 326 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $2,839,113,187 to $3,007,204,873.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 326 institutions filings for Q1 2026.
Security key
868459108
Latest holder period
Q1 2026
13F holders
326
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
SUPN full holder history
SUPERNUS PHARMACEUTICALS, INC. SEC filings
SUPERNUS PHARMACEUTICALS, INC. company facts
SUPERNUS PHARMACEUTICALS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 868459108:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
SUPN
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 15% | $266,321,277 | 8,197,023 | BlackRock, Inc. | 31 Mar 2025 | |||
| MILLENNIUM MANAGEMENT LLC | 5.7% | +8% | $161,652,355 | +$12,092,936 | 3,281,615 | +8.1% | Millennium Management LLC | 11 Feb 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.7% | $168,680,442 | 3,263,309 | Vanguard Portfolio Management | 31 Mar 2026 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5% | $149,946,694 | 2,900,884 | Vanguard Capital Management | 31 Mar 2026 | |||
| ARMISTICE CAPITAL, LLC | 4.8% | -4.8% | $136,154,640 | -$3,546,720 | 2,764,000 | -2.5% | Armistice Capital, LLC | 31 Dec 2025 |
| DIMENSIONAL FUND ADVISORS LP | 4.7% | $134,803,348 | 2,712,341 | Dimensional Fund Advisors LP | 31 Dec 2025 |
As of 31 Mar 2026, 326 institutional investors reported holding 58,220,522 shares of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN). This represents 101% of the company’s total 57,671,650 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
76%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 15% | 8,797,254 | +0.7% | 0.01% | $454,730,061 |
| MILLENNIUM MANAGEMENT LLC | 5.7% | 3,315,973 | +26% | 0.13% | $171,402,644 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.6% | 3,238,693 | 0% | 0.01% | $167,408,041 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 2,467,215 | 0% | 0% | $127,530,343 |
| DIMENSIONAL FUND ADVISORS LP | 4% | 2,307,030 | -15% | 0.02% | $119,239,273 |
| STATE STREET CORP | 4% | 2,288,127 | +3.1% | 0% | $118,273,285 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 3.5% | 2,037,202 | -12% | 0.18% | $105,303,000 |
| ARMISTICE CAPITAL, LLC | 3.3% | 1,895,347 | -31% | 3.2% | $97,970,486 |
| RENAISSANCE TECHNOLOGIES LLC | 3% | 1,705,222 | -1.6% | 0.14% | $88,142,925 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.8% | 1,623,514 | +10% | 0.01% | $83,933,938 |
| CITADEL ADVISORS LLC | 2.6% | 1,493,446 | +230% | 0.05% | $77,196,223 |
| LOOMIS SAYLES & CO L P | 2.5% | 1,425,779 | -1.6% | 0.1% | $73,698,522 |
| Stephens Investment Management Group LLC | 2.3% | 1,351,331 | -3.9% | 0.96% | $69,850,299 |
| Point72 Asset Management, L.P. | 2.3% | 1,318,555 | -42% | 0.12% | $68,156,108 |
| GW&K Investment Management, LLC | 1.8% | 1,055,184 | -2.4% | 0.48% | $54,542,000 |
| Sofinnova Investments, Inc. | 1.7% | 954,309 | +73% | 2.5% | $49,328,232 |
| MORGAN STANLEY | 1.6% | 913,893 | -15% | 0% | $47,239,157 |
| GOLDMAN SACHS GROUP INC | 1.5% | 856,487 | +30% | 0.01% | $44,271,813 |
| BANK OF AMERICA CORP /DE/ | 1.2% | 714,226 | +37% | 0% | $36,918,329 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2% | 705,976 | +0.33% | 0.01% | $36,491,899 |
| NORTHERN TRUST CORP | 1.2% | 699,456 | +4.3% | 0% | $36,154,881 |
| ASHFORD CAPITAL MANAGEMENT INC | 1.1% | 645,381 | +5.4% | 4.1% | $33,359,744 |
| Freestone Grove Partners LP | 1.1% | 641,319 | +227% | 0.24% | $33,149,779 |
| D. E. Shaw & Co., Inc. | 1.1% | 622,450 | -12% | 0.03% | $32,174,441 |
| Assenagon Asset Management S.A. | 0.92% | 530,618 | 0.04% | $27,427,644 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 58,220,522 | $3,007,204,873 | +$59,274,476 | $51.69 | 326 |
| 2025 Q4 | 57,114,664 | $2,839,113,187 | -$131,385,144 | $49.70 | 332 |
| 2025 Q3 | 57,682,442 | $2,756,480,706 | -$55,160,794 | $47.79 | 306 |
| 2025 Q2 | 59,473,450 | $1,874,807,260 | +$9,630,477 | $31.52 | 292 |
| 2025 Q1 | 59,101,687 | $1,935,404,930 | -$15,482,554 | $32.75 | 289 |
| 2024 Q4 | 59,487,720 | $2,151,322,834 | -$22,020,752 | $36.16 | 289 |
| 2024 Q3 | 59,870,229 | $1,866,730,333 | +$55,809,134 | $31.18 | 269 |
| 2024 Q2 | 58,408,045 | $1,562,624,874 | +$31,544,259 | $26.75 | 241 |
| 2024 Q1 | 56,687,119 | $1,933,242,340 | -$13,205,166 | $34.11 | 246 |
| 2023 Q4 | 57,120,264 | $1,653,064,952 | +$17,403,885 | $28.94 | 244 |
| 2023 Q3 | 56,959,606 | $1,570,365,603 | -$13,068,601 | $27.57 | 235 |
| 2023 Q2 | 57,192,976 | $1,719,305,714 | +$49,379,666 | $30.06 | 244 |
| 2023 Q1 | 55,275,699 | $2,002,621,195 | -$15,673,429 | $36.23 | 254 |
| 2022 Q4 | 55,885,167 | $1,993,935,462 | +$8,207,715 | $35.67 | 259 |
| 2022 Q3 | 55,685,346 | $1,884,907,309 | +$24,605,478 | $33.85 | 236 |
| 2022 Q2 | 54,730,295 | $1,582,868,015 | +$42,197,813 | $28.92 | 214 |
| 2022 Q1 | 53,502,805 | $1,728,247,579 | -$41,233,819 | $32.32 | 220 |
| 2021 Q4 | 55,217,286 | $1,609,193,475 | +$18,456,601 | $29.16 | 226 |
| 2021 Q3 | 54,377,202 | $1,451,011,413 | +$3,672,754 | $26.67 | 217 |
| 2021 Q2 | 54,148,773 | $1,667,192,127 | +$29,163,166 | $30.79 | 222 |
| 2021 Q1 | 53,335,145 | $1,397,017,874 | +$13,336,729 | $26.18 | 217 |
| 2020 Q4 | 52,923,548 | $1,331,865,761 | +$29,078,257 | $25.16 | 219 |
| 2020 Q3 | 51,463,966 | $1,072,432,929 | +$15,343,379 | $20.84 | 204 |
| 2020 Q2 | 50,545,295 | $1,200,362,920 | +$48,582,918 | $23.75 | 213 |
| 2020 Q1 | 48,465,165 | $871,862,986 | -$52,617,228 | $17.99 | 199 |